Drug Approval | August 20, 2021
US FDA approves Jardiance to treat adults living with heart failure with a reduced ejection fraction
New treatment options are critical, as approximately half of all people with heart failure die within five years of diagnosis. Heart failure accounts for more than one million hospitalisations a year in the US
